semaglutide and tsh levels effects on thyroid Study: Patients With Hypothyroidism Who Lost Weight Saw Decreases in Semaglutide-induced Subclinical Hypothyroidism: A Case – Suppressed thyroid stimulating hormone levels

Stated precautions and adverse reactions associated with the use of Rybelsus: Nausea Abdominal pain Diarrhea Decreased appetite Vomiting Constipation Acute Pancreatitis Diabetic retinopathy complications Hypoglycemia (with concomitant use of insulin secretagogues or Insulin) Acute kidney injury due to volume depletion Severe gastrointestinal adverse reaction Hypersensitivity reactions Acute gallbladder disease Pulmonary aspiration during general anesthesia or deep sedation: Individuals who suffered these or other side effects after using Rybelsus may be able to take legal action against the manufacturer for a failure to adequately warn consumers of the adverse effects of using the drug

The safety profile of tirzepatide was also favorable, with a low incidence of hypoglycemia and serious adverse events

Patients on the 25mg maintenance dose lost an average of around 13.6% of their body weight over 64 weeks

However, Wegovy is an anti-obesity medication that is FDA-approved for those with a BMI of 30 or higher or those with a BMI of 27 or higher with a comorbid condition like sleep apnea or high blood pressure